Nathan J. Davis

Mr. Davis’ experience includes advising:

Technology

• Vista Equity Partners in its US$3.5 billion acquisition of Pluralsight*
• Vista Equity Partners, Bain Capital Private Equity, and Vertafore in the US$5.35 billion sale of Vertafore*
• Vista Equity Partners in its US$1.5 billion investment in Jio Platforms*
• Oaktree Capital Management in its growth equity investment in REEF*
• A private equity sponsor in its majority investment in a market leader in resource management software for utilities, airlines, and other critical infrastructure industries*
• A private equity sponsor in its acquisition of a trusted provider of environmental, health, safety, and quality (EHSQ) software*
• A private equity sponsor in its acquisition of a contractor management software and safety learning content provider that helps both hiring clients and contractors manage risk, safety, and compliance*
• A private equity sponsor’s portfolio company in its acquisition of a provider of key solutions required to enhance safety for the workforce of leading organizations and the communities they serve*
• TCV in its acquisition of EtQ, a global leader in quality management system (QMS) and environmental, health, and safety (EHS) software*
• Inteliquent, a premier interconnection partner for communications service providers, in its sale to GTCR and Onvoy*

Healthcare

• Oaktree Acquisition Corp., a special purpose acquisition company (SPAC) sponsored by an affiliate of Oaktree Capital Management, on its US$1.6 billion business combination with Hims*
• Arsenal Capital Partners in its acquisition and combination of Caprion and HistoGeneX to create a global leader in immune monitoring, protein characterization, and tissue pathology solutions for immunotherapy and drug development*
• Arsenal Capital Partners’ portfolio company BioIVT in its acquisition of Asterand Bioscience, a global provider of high-quality, well-characterized human tissue and research solutions with a focus on the oncology market*
• Bain Capital Private Equity in its investment in Surgery Partners and Surgery Partners’ simultaneous acquisition of National Surgical Healthcare*
• TA Associates in its acquisition of Healix, a leading provider of infusion therapy management services and compounded intravenous pharmaceuticals for physician practices and hospitals*

Industrials

• Arsenal Capital Partners in its sale of Inhance Technologies, a provider of fluorine-based material technologies, to Aurora Capital Partners*
• Arsenal Capital Partners in its sale of Flowchem, a leading manufacturer of pipeline performance products, to KMG*
• Arsenal Capital Partners in its acquisition of Phoenix Chemical, a specialty chemical manufacturer and distributor focused on the carpet, textile, water treatment, and household, industrial, and institutional chemicals markets*
• Frontenac Company in its sale of H-E Parts International, the leading independent global provider of aftermarket parts, components, and solutions for the mining, heavy construction, and energy sectors to Hitachi Construction Machinery*
• A private equity sponsor in its acquisition of a specialty materials company*
• A private equity sponsor’s portfolio company in its acquisition of a leader in the preventive maintenance field, engineering design, and installation of HVAC and control systems in industrial and commercial facilities*

Other Industries

• Oaktree Capital Management in its investment in System One Holdings, a leading provider of specialized workforce solutions and integrated services*
• Prairie Capital in its sale of Elektra Holding Company, the parent company of Chicago Deferred Exchange, a premier provider of Qualified Intermediary services for taxpayers seeking to structure tax-deferred like-kind exchanges under Internal Revenue Code Section 1031, to Wintrust Financial Corporation*
• A private equity sponsor in its acquisition of a provider in the funeral services industry*
• A private equity sponsor in its acquisition of a franchisor of restaurants*
• A high-end fashion retailer on a simultaneous bankruptcy plan sale of IP and operating assets*

*Matter handled prior to joining Latham